Todos Med (QB) Stock Price

0.0009 (5.11%)
Volume 2,671,216
Bid Price 0.012
Ask Price 0.0196
News -
Day High 0.0196


52 Week Range


Day Low 0.01525
Company Name Stock Ticker Symbol Market Type
Todos Med Ltd (QB) TOMDF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0009 5.11% 0.0185 16:33:09
Open Price Low Price High Price Close Price Prev Close
0.0196 0.01525 0.0196 0.0185 0.0176
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
91 2,671,216 $ 0.017639 $ 47,117 - 0.0103 - 0.644
Last Trade Time Type Quantity Stock Price Currency
15:59:31 100 $ 0.0185 USD


Draw Mode:

Todos Med Ltd (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 25.06M 1.35B 607.86M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
24.86k $ - - - -

more financials information »

Todos Med (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TOMDF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.01650.0250.01210.0172465,821,6220.00212.12%
1 Month0.03650.0390.01210.02179417,497,624-0.018-49.32%
3 Months0.01280.0420.01030.026008911,110,3310.005744.53%
6 Months0.02640.0420.01030.02254687,674,649-0.0079-29.92%
1 Year0.0410.6440.01030.03693557,966,725-0.0225-54.88%
3 Years0.1990.6440.01030.0453834,574,405-0.1805-90.7%
5 Years0.900.900.01030.04550093,798,983-0.8815-97.94%

Todos Med (QB) Description

Founded in Rehovot, Israel with offices in New York City, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic solutions for the early detection of a variety of cancers. The Company's state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that examines cancer's influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma. Todos' two internally developed cancer-screening tests, TMB-1 and TMB-2 have received a CE mark in Europe. Todos recently acquired U.S.-based medical diagnostics company Provista Diagnostics, Inc. to gain rights to its Alpharetta, Georgia-based CLIA/CAP certified lab currently performing PCR COVID testing, Long COVID Panel, and Provista's proprietary commercial-stage Videssa breast cancer blood test.

Your Recent History
Todos Med ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now